Pallas Capital Advisors »

Ishares Tr genomics immun shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $200k 8.3k 24.08
2023-12-31 $472k 21k 23.01
2023-09-30 $536k 30k 17.73
2023-06-30 $428k 18k 24.00

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Global Partners Com Units (GLP)
Microsoft Corporation (MSFT)
Amazon (AMZN)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Apple (AAPL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Alphabet Cap Stk Cl A (GOOGL)
Principal Exchange Traded Spectrum Pfd (PREF)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Indexiq Active Etf Tr Iq Mackay Intrme (MMIT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Broadcom (AVGO)

View all positions for Pallas Capital Advisors

Top funds holding Ishares Tr genomics immun

Jane Street
Wharton Business Group
Bank of America Corporation
UBS Group
Royal Bank of Canada
Bsc Private Wealth Management
Commonwealth Equity Services
Advisor Group Holdings
Cora Capital Advisors
Citadel Advisors
Visionary Wealth Advisors
Raymond James Financial Services Advisors
Branch Banking & Trust Company
TCG Advisory Services
PFG Investments

View all funds holding Ishares Tr genomics immun